How Combined Macrolide Nanomaterials are Effective Against Resistant Pathogens? A Comprehensive Review of the Literature

Ebrahim Abdela Siraj,1,2 Ashagrachew Tewabe Yayehrad,1 Anteneh Belete2 1Department of Pharmacy, School of Health Sciences, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia; 2Department of Pharmaceutics and Social Pharmacy, School of Pharmacy, College of Medicine and...

Full description

Bibliographic Details
Published in:	International Journal of Nanomedicine
Main Authors:	Siraj EA, Yayehrad AT, Belete A
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-09-01
Subjects:	macrolides nanomedicine drug resistance macrolide nano-delivery
Online Access:	https://www.dovepress.com/how-combined-macrolide-nanomaterials-are-effective-against-resistant-p-peer-reviewed-fulltext-article-IJN

Similar Items

Macrolides Decrease the Proinflammatory Activity of Macrolide-Resistant Streptococcus pneumoniae
by: Hisanori Domon, et al.
Published: (2023-06-01)

The clinical significance of and the factors associated with macrolide resistance and poor macrolide response in pediatric Mycoplasma pneumoniae infection: A retrospective study
by: Meng-Hsiu Yen, et al.
Published: (2023-06-01)

Severe problem of macrolides resistance to common pathogens in China
by: Jialin Li, et al.
Published: (2023-08-01)

Macrolide versus Non-Macrolide in Combination with Steroids for the Treatment of Lobar or Segmental <i>Mycoplasma pneumoniae</i> Pneumonia Unresponsive to Initial Macrolide Monotherapy
by: Eunha Bae, et al.
Published: (2022-09-01)

Cardiac Toxicity of Macrolide Antibiotics
by: Galeeva Zh.A., et al.
Published: (2015-11-01)

Use of macrolides in lung diseases: recent literature controversies
by: Luiz Vicente Ribeiro Ferreira da Silva Filho, et al.
Published: (2015-11-01)

Immunomodulatory Effects of Macrolides Considering Evidence from Human and Veterinary Medicine
by: Joseph M. Blondeau
Published: (2022-12-01)

Macrolide Resistance in <i>Bordetella pertussis</i>: Current Situation and Future Challenges
by: Lauri Ivaska, et al.
Published: (2022-11-01)

Macrolides: Indications and Contraindications
by: Xavier Pomares
Published: (2023-01-01)

A Review Study on Macrolides Isolated from Cyanobacteria
by: Mengchuan Wang, et al.
Published: (2017-04-01)

Macrolides: From Toxins to Therapeutics
by: Kiersten D. Lenz, et al.
Published: (2021-05-01)

Genotypic Characterization of Macrolides Resistance in Clinical Isolates of Staphylococcus Aureus from Rawalpindi, Pakistan
by: Iram Manzoor, et al.
Published: (2024-06-01)

Computational Studies on Selected Macrolides Active against <i>Escherichia coli</i> Combined with the NMR Study of Tylosin A in Deuterated Chloroform
by: Biljana Arsic, et al.
Published: (2022-10-01)

The effect of milk on plasmatic and tissue levels of macrolides: in vivo study in rats
by: F. C. Groppo, et al.
Published: (2009-01-01)

Macrolide Allergic Reactions
by: Kristy M. Shaeer, et al.
Published: (2019-09-01)

A systematic review and meta-analysis of macrolides in the management of adult patients with asthma
by: Hiroshi Ohnishi, et al.
Published: (2024-07-01)

Stress Degradation Studies of Macrolide Antibiotics “Roxithromycin, Tilmicosin and Tylosin” by Using HPLC
by: Bediha Akmese
Published: (2020-03-01)

Epidemiology and clinical manifestations of children with macrolide-resistant Mycoplasma pneumoniae pneumonia in Southern Taiwan
by: Chih-Hao Chang, et al.
Published: (2021-09-01)

Efficacy of doxycycline therapy for macrolide-resistant Mycoplasma pneumoniae pneumonia in children at different periods
by: Ying Chen, et al.
Published: (2024-03-01)

Macrolide Treatment Failure due to Drug–Drug Interactions: Real-World Evidence to Evaluate a Pharmacological Hypothesis
by: Brian Cicali, et al.
Published: (2022-03-01)

Adverse drug reactions of macrolide therapy: analysis of spontaneous reports according to the Pharmacovigilance system
by: Skryabina A.A., et al.
Published: (2023-03-01)

Macrolide-resistant phenotypes of invasive streptococcus pneumoniae isolates in Serbia
by: Gajić Ina, et al.
Published: (2012-01-01)

The Effectiveness and Safety of Long-Term Macrolide Therapy for COPD in Stable Status: A Systematic Review and Meta-Analysis
by: Kazunori Nakamura, et al.
Published: (2023-10-01)

Clinical Efficacy of Doxycycline for Treatment of Macrolide-Resistant <i>Mycoplasma pneumoniae</i> Pneumonia in Children
by: Hyunju Lee, et al.
Published: (2021-02-01)

Macrolide-Resistant Mycoplasma pneumoniae Infection, Japan, 2008–2015
by: Takaaki Tanaka, et al.
Published: (2017-10-01)

Macrolide Antibiotic Mediated Cardiac Arrhythmias: Emerging Concepts and Clinical Implications
by: Fatima Iqbal, et al.
Published: (2025-06-01)

Mechanisms of Resistance to Macrolide Antibiotics among <i>Staphylococcus aureus</i>
by: Maria Miklasińska-Majdanik
Published: (2021-11-01)

The Clinical Significance of Pathogen Loads and Macrolide Resistance Levels for Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Children
by: Leng M, et al.
Published: (2024-10-01)

Molecular epidemiology and increasing macrolide resistance of Bordetella pertussis isolates in Guangzhou, China
by: Qiongdan Mai, et al.
Published: (2025-09-01)

Clinical Manifestations, Macrolide Resistance, and Treatment Utilization Trends of <i>Mycoplasma pneumoniae</i> Pneumonia in Children and Adolescents in South Korea
by: Joon Kee Lee, et al.
Published: (2024-08-01)

Synthesis and Antibacterial Activity of ll-O-(Benzoxaborole-Aminoalkylcarbamoyl) Derivatives of Macrolide Antibiotic Azithromycin
by: S. S. Printsevskaya, et al.
Published: (2020-05-01)

Impact of macrolide antibiotics on gut microbiota diversity with age-specific implications and scientific insights
by: H. Shayista, et al.
Published: (2025-06-01)

Pharmacokinetics of Macrolide Antibiotics and Transport into the Interstitial Fluid: Comparison among Erythromycin, Clarithromycin, and Azithromycin
by: Shinji Kobuchi, et al.
Published: (2020-04-01)

Insights into Helicobacter pylori macrolide resistance: a comprehensive systematic review and meta-analysis
by: Safoura Morad Kasani, et al.
Published: (2024-10-01)

Macrolides in the modern therapy of community-acquired pneumonia in children
by: Yu. L. Mizernitskiy
Published: (2020-11-01)

FIVE REASONS TO PRESCRIBE A MACROLIDE FOR ENT DISEASE
by: V. V. SHILENKOVA
Published: (2016-12-01)

Persistent high macrolide resistance rate and increase of macrolide-resistant ST14 strains among Mycoplasma pneumoniae in South Korea, 2019–2020
by: Joon Kee Lee, et al.
Published: (2022-10-01)

Antibiotic Potentiation as a Promising Strategy to Combat Macrolide Resistance in Bacterial Pathogens
by: Deepjyoti Paul, et al.
Published: (2023-12-01)

Adsorption of Macrolide Antibiotics and a Metabolite onto Polyethylene Terephthalate and Polyethylene Microplastics in Aquatic Environments
by: Carmen Mejías, et al.
Published: (2024-04-01)

Macrolide-refractory Mycoplasma pneumoniae pneumonia and hemophagocytic lymphohistiocytosis: case report and literature review
by: Sung-Yun Ma, et al.
Published: (2020-12-01)